2 completed, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Fingolimod: new trials by email Literature Review of Fingolimod trials Research Report on Fingolimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage Fingolimod - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Unknown | Tang-Du Hospital | 40 | 2023-10-11 | 2023-10-18 |
| Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer Fingolimod, Fingolimod Hydrochloride, Questionnaire Administration - Breast Carcinoma | Phase 1 | Completed | Mayo Clinic | 2 | 2019-12-12 | 2023-07-21 |
| A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303 MT-1303-Low, MT-1303-High, Fingolimod - Relapsing-remitting Multiple Sclerosis | Phase 1 | Completed | Tanabe Pharma Corporation | 81 | 2015-02-20 |
Breast Neoplasms (1) · Cerebral Hemorrhage (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Mayo Clinic (1) · Tanabe Pharma Corporation (1) · Tang-Du Hospital (1)
United Kingdom (1) · United States (1)
Charles L Loprinzi (1) · Peter Sowood, M.D (1) · Yan Qu (1)
P30CA015083 (1)